FDA Approves IMODIUM MULTI-SYMPTOM RELIEF — Kenvue Brands LLC

# FDA Approval Newswire Kenvue Brands LLC has received FDA approval for IMODIUM Multi-Symptom Relief, an oral combination formulation of loperamide hydrochloride and dimethicone, expanding its over-the-counter gastrointestinal product portfolio. The dual-action formulation addresses both diarrhea and gas symptoms, potentially strengthening Kenvue's competitive position in the $2+ billion OTC digestive health market.